JezK
Edit File: 1632239990.M223117P2279559.mocha3025.mochahost.com,S=10212,W=10362
Return-Path: <bounces+13288428-34de-dr.sultan=jack.ngo@em3451.selectscience.com> Delivered-To: dr.sultan@jack.ngo Received: from mocha3025.mochahost.com by mocha3025.mochahost.com with LMTP id KIv6C3YBSmGHyCIAaMJ/gg (envelope-from <bounces+13288428-34de-dr.sultan=jack.ngo@em3451.selectscience.com>) for <dr.sultan@jack.ngo>; Tue, 21 Sep 2021 11:59:50 -0400 Return-path: <bounces+13288428-34de-dr.sultan=jack.ngo@em3451.selectscience.com> Envelope-to: dr.sultan@jack.ngo Delivery-date: Tue, 21 Sep 2021 11:59:50 -0400 Received: from o1.ptr5290.selectscience.com ([167.89.92.117]:60286) by mocha3025.mochahost.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384 (Exim 4.94.2) (envelope-from <bounces+13288428-34de-dr.sultan=jack.ngo@em3451.selectscience.com>) id 1mSiBR-009eyP-Rl for dr.sultan@jack.ngo; Tue, 21 Sep 2021 11:59:50 -0400 DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=selectscience.com; h=mime-version:from:subject:content-type:content-transfer-encoding:to; s=s1; bh=8lauYsASum9d9hDaeMUb7q1w/u4GYd9irJXiky23hGA=; b=Mgd1O3VWNR4VWckT03HjEPVo/bODpxVnLed6Vz4P1r9I8fspdDwJFfg9/Zpp2sZH0v4A TO3Avk8PbDnBnwUcjIKbsHA+IdVdDyIPCqmVXjFisEiZ0dXy/5nH7Z7dfpZa8LCu/kM8Rt AoZnxSL7oQqIkFz0OHrhnSwCLjal28lq6PARpJvWTZsRtE7KDLNudYJ4LWDJoGGi0grbbC gB+bbx6Vz+ek+KEGhZWgR8yNTPTCASQDGl3ntJ0uCRpgz00UtqcnsUeniagajCdu0e+HbJ 1jxRG3PbH9DX1mz6cCAuEcBBj9H6aWkWk8KjvbQo7BS7nTRI00JIkZyvXi7Lj3hA== Received: by filterdrecv-794785844b-dpgwp with SMTP id filterdrecv-794785844b-dpgwp-1-614A0145-6B 2021-09-21 15:59:01.688949613 +0000 UTC m=+1705085.058430395 Received: from SS-WEB01 (unknown) by geopod-ismtpd-canary-0 (SG) with ESMTP id 2t3soIW0Q_ikUML23oapwQ for <webinars@selectscience.com>; Tue, 21 Sep 2021 15:59:01.534 +0000 (UTC) MIME-Version: 1.0 From: Charlie Carter <webinars@selectscience.com> Date: Tue, 21 Sep 2021 15:59:09 +0000 (UTC) Subject: [Register Now] CAR-T cells as a model for clinical development & commercialization Content-Type: text/html; charset=us-ascii Content-Transfer-Encoding: quoted-printable Message-ID: <2t3soIW0Q_ikUML23oapwQ@geopod-ismtpd-canary-0> X-SG-EID: =?us-ascii?Q?aWD1EYVVAMUKgUgnBNhErXGaZDsv72s6nINH7cSMRWpaUMWZIGdSgWxWG1nkOa?= =?us-ascii?Q?e9NZq5sQKTPPKhTUT8t=2FcBMC01+D5eOqall4QWK?= =?us-ascii?Q?YzzTMNOsIuDv5ebxySVRiZYFrgyhZIgdKIpvoyN?= =?us-ascii?Q?5VBx8x+3JU=2F7dFvw43mFQuBAqX2FpG0H0SDglRx?= =?us-ascii?Q?7MDpgdvJp1aW37mI97vqWGdPoIRMLDt6aOVpJsx?= =?us-ascii?Q?8sXGWfoOiHIs4Rk88eZDb32A1En6ecUX3xfe6tO?= =?us-ascii?Q?ece95MyXbLow88SVTsVLg=3D=3D?= To: dr.sultan@jack.ngo X-Entity-ID: LHjqSk4arHVPSAxn7el6bQ== <!--[if !mso 9]><!--><p><span style=3D"display:none !important; visibility:= hidden;opacity:0;color:transparent;height:0;width:0;">Free CAR-T cell webin= ar = </span></p> <div style=3D"display: none; max-height: 0px; over= flow: hidden;"> ‌ ‌ ‌ ‌ ‌= ‌ ‌ ‌ ‌ ‌ ‌&nb= sp;‌ ‌ </div><!--<![endif]--><p><span style=3D"text-ali= gn: left; color: rgb(0, 0, 0); font-family: Calibri, sans-serif; font-size:= 11pt;">Dear Colleague,<br /><br />New designs for genetically engineered T= cells include switches and potency enhancements that will be required for = targeting solid tumors. The road forward for wide patient access to these u= niquely personal cellular therapies depends on a number of considerations. = <br /><br />Join Dr. Bruce Levine on Wednesday, September 22, as he explore= s CAR-T cells, their mechanisms, development, and complexities: <br /><br /= > <strong><u> <a href=3D"http://www.selectscience.net/go/?itemID=3D79&= itemTypeID=3D4&linkID=3Dregnowtext&mailID=3D16269&email=3Ddr.su= ltan@jack.ngo&URL=3Dhttps%3A%2F%2Fwww.selectscience.net%2Fregister.aspx= %3FitemID%3D1621%26itemTypeID%3D54%26referrer%3Dselectsciencepromo-3%26utm_= source%3DMembers%26utm_medium%3DWebinar-Email%26utm_campaign%3DSartorius-Se= ptember-2021" style=3D" font-family: Calibri, sans-serif; font-size: 11pt; = color: black;" target=3D"_blank">From boutique to global: Chimeric antigen = receptor T cells as a model for clinical development and commercialization<= /a></u></strong> <br /><br /> <a href=3D"http://www.selectscience.net/go/?= itemID=3D79&itemTypeID=3D4&linkID=3Dregnowtext&mailID=3D16269&a= mp;email=3Ddr.sultan@jack.ngo&URL=3Dhttps%3A%2F%2Fwww.selectscience.net= %2Fregister.aspx%3FitemID%3D1621%26itemTypeID%3D54%26referrer%3Dselectscien= cepromo-3%26utm_source%3DMembers%26utm_medium%3DWebinar-Email%26utm_campaig= n%3DSartorius-September-2021" style=3D" font-family: Calibri, sans-serif; f= ont-size: 11pt;" target=3D"_blank">Register now</a> and attend the webinar = to understand:<br /> <ul><li><span style=3D"text-align: left; color: rgb(0,= 0, 0); font-family: Calibri, sans-serif; font-size: 11pt;">The mechanism o= f action and desirable characteristics of CAR-T cells</span></li><li><span = style=3D"text-align: left; color: rgb(0, 0, 0); font-family: Calibri, sans-= serif; font-size: 11pt;">The challenges of clinical development from bench = to bedside of a CAR-T therapy</span></li><li><span style=3D"text-align: lef= t; color: rgb(0, 0, 0); font-family: Calibri, sans-serif; font-size: 11pt;"= >The vein-to-vein complexities and healthcare challenges of developing a pa= radigm shift in therapies</span></li> </ul> <p><span style=3D"text-align= : left; color: rgb(0, 0, 0); font-family: Calibri, sans-serif; font-size: 1= 1pt;"><table><tbody><tr><td style=3D"background-color: #36b156; padding: 10= px 10px 10px 10px;"><span style=3D"text-align: left; color: rgb(0, 0, 0); f= ont-family: Calibri, sans-serif; font-size: 11pt;"><a href=3D"http://www.se= lectscience.net/go/?itemID=3D79&itemTypeID=3D4&linkID=3Dctabutton&a= mp;mailID=3D16269&email=3Ddr.sultan@jack.ngo&URL=3Dhttps%3A%2F%2Fww= w.selectscience.net%2Fregister.aspx%3FitemID%3D1621%26itemTypeID%3D54%26ref= errer%3Dselectsciencepromo-3%26utm_source%3DMembers%26utm_medium%3DWebinar-= Email%26utm_campaign%3DSartorius-September-2021" style=3D"text-decoration: = none; color: #ffffff; font-family: Arial;" target=3D"_blank"><strong>Regist= er now »</strong></a></span></td></tr></tbody></table><br /><br /><sp= an style=3D"text-align: left; color: rgb(0, 0, 0); font-family: Calibri, sa= ns-serif; font-size: 11pt;"><strong>All webinar participants can request a = certificate of attendance, including a learning outcomes summary, for conti= nuing education purposes - <a href=3D"http://www.selectscience.net/go/?it= emID=3D79&itemTypeID=3D4&linkID=3Dregnowtext&mailID=3D16269&= ;email=3Ddr.sultan@jack.ngo&URL=3Dhttps%3A%2F%2Fwww.selectscience.net%2= Fregister.aspx%3FitemID%3D1621%26itemTypeID%3D54%26referrer%3Dselectscience= promo-3%26utm_source%3DMembers%26utm_medium%3DWebinar-Email%26utm_campaign%= 3DSartorius-September-2021" style=3D" font-family: Calibri, sans-serif; fon= t-size: 11pt;" target=3D"_blank">register now</a>.</strong></span><br /><br= /> <span style=3D"text-align: left; color: rgb(0, 0, 0); font-family: C= alibri, sans-serif; font-size: 11pt;"><span style=3D"text-align: left; colo= r: rgb(0, 0, 0); font-family: Calibri, sans-serif; font-size: 11pt;">Please= feel free to forward this email to any colleagues or friends that may be i= nterested.</span><br /><br /><span style=3D"text-align: left; color: rgb(0,= 0, 0); font-family: Calibri, sans-serif; font-size: 11pt;">Kind regards,<b= r /><br />Charlie Carter<br />Associate Editor<br /><strong>SelectScience&r= eg; - <em>The Fastest Way to Expert Opinion™</em> </strong><br /><br = />e: <a href=3D"http://www.selectscience.net/go/?itemID=3D79&itemTypeID= =3D4&linkID=3Dmailto&mailID=3D16269&email=3Ddr.sultan@jack.ngo&= amp;URL=3Dhttp%3A%2F%2Fwww%2Eselectscience%2Enet%2Fcontact%2Easpx%3FitemID%= 3D16269%26itemTypeID%3D22%26utm_source%3DMembers%26utm_medium%3DWebinar-Ema= il%26utm_campaign%3DSartorius-September-2021" target=3D"_blank">editor@sele= ctscience.net</a><br />t: +44 1225 874666<br />f: +44 1225 874123<br />w: <= a href=3D"http://www.selectscience.net/go/?itemID=3D79&itemTypeID=3D4&a= mp;linkID=3Dwebsite&mailID=3D16269&email=3Ddr.sultan@jack.ngo&U= RL=3Dhttp%3A%2F%2Fwww.selectscience.net%2Findex.aspx%3Futm_source%3DMembers= %26utm_medium%3DWebinar-Email%26utm_campaign%3DSartorius-September-2021" ta= rget=3D"_blank">http://www.selectscience.net</a><br />a: SelectScience Ltd,= Science House, Church Farm Business Park, Corston, Bath, BA2 9AP, UK</span= ><br /><br /><strong><span style=3D"color:#ff0000; text-align: left; font-f= amily: Calibri, sans-serif; font-size: 11pt;">We are recruiting: <a href=3D= "http://www.selectscience.net/go/?itemID=3D79&itemTypeID=3D4&linkID= =3Dcareers&mailID=3D16269&email=3Ddr.sultan@jack.ngo&URL=3Dhttp= %3A%2F%2Fwww.selectscience.net%2Fcareer%2F%3Futm_source%3DMembers%26utm_med= ium%3DWebinar-Email%26utm_campaign%3DSartorius-September-2021" target=3D"_b= lank">View opportunities today »</a></span></strong></span><br /><br = /><span style=3D"text-align: left; color: rgb(0, 0, 0); font-family: Calibr= i; font-size: 8pt;">SelectScience® is a registered trademark. The conte= nt of this email may be privileged and is confidential. It may not be discl= osed to or used by anyone other than the intended recipient(s), nor copied = in any way. If received in error, please advise the sender and delete it fr= om your system. SelectScience Limited, VAT registration 1: 713563055. Compa= ny registration 1: 3597730. Registered office: The Old Boardroom, Collett R= oad, Ware, Herts, SG12 7LR, UK<img border=3D"0" height=3D"1" src=3D"http://= www.selectscience.net/trackOpenRate.aspx?mailID=3D16269&email=3Ddr.sult= an@jack.ngo" width=3D"1" /></span><br /><br /><a href=3D"http://www.selects= cience.net/SSUserUnSubscription.aspx?mailID=3D16269&email=3Ddr.sultan@j= ack.ngo" style=3D"COLOR: #000000; font-family:Calibri, Arial, Sans-Serif; f= ont-size:9pt" target=3D"_blank">Click here to unsubscribe</a></p>